Unicycive Therapeutics (UNCY) Stock Price

Live Unicycive Therapeutics Stock Price, Historical UNCY Stock Price Chart

24H Range
 
 
 
52W Range
 
 
 
Last Price $ 3.55
Open $ 3.63
Previous Close $ 3.64
Volume $ 2.43M
ATH $ 87.30 (-95.93%)
ExchangeNASDAQ
P/E Ratio (TTM) -2.03
EPS (TTM) -$ 1.75
Annual Dividend (Yield) -
Market Cap $ 97.25M
Unicycive Therapeutics Performance
Prev. Close 7 Days 1 Month 3 Months 6 Months 1 Year YTD 5 Year Max
-2.47% -4.05% 5.65% -36.27% -54.08% -38.47% -38.79% -87.04% -92.90%

About Unicycive Therapeutics

Statistics

The Unicycive Therapeutics stock price is currently $ 3.55 with a total market cap valuation of $ 97.25M (27.39M shares outstanding). The Unicycive Therapeutics is trading on NASDAQ under the ticker sign UNCY. Unicycive Therapeutics price is up -2.47% in the past 24 hours. The Unicycive Therapeutics stock price prediction is currently bullish.

Description

Company Profile

News

Unicycive Therapeutics to Present at the Guggenheim 3rd Annual Healthcare Innovation Conference
CLASS ACTION DEADLINE TONIGHT: Faruqi & Faruqi, LLP Reminds Unicycive Therapeutics (NASDAQ: UNCY) Investors of Securities Class Action Lawsuit Deadline on November 2, 2026
Levi & Korsinsky Reminds Unicycive Therapeutics Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of November 2, 2026 - UNCY
Bronstein, Gewirtz & Grossman LLC Urges Unicycive Therapeutics, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
UNCY UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Unicycive Therapeutics (UNCY) Investors of Securities Class Action Lawsuit Deadline on November 2, 2026
UNCY URGENT DEADLINE: Unicycive Therapeutics, Inc. Investors Have Until November 2nd to Contact Bragar Eagel & Squire, P.C. Seeking Lead Plaintiff Role
Unicycive Therapeutics: 95% Upside Priced Against A Wall Of Dilution And Regulatory Risk
UNCY CLASS ACTION NOTICE: Faruqi & Faruqi, LLP Reminds Unicycive Therapeutics (UNCY) Investors of Securities Class Action Lawsuit Deadline on November 2, 2026
Kaplan Fox Alerts Investors: Lead Plaintiff Deadline for Unicycive Therapeutics, Inc. (UNCY) is November 2, 2026
UNCY Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Unicycive Therapeutics Securities Lawsuit - Contact SueWallSt

Download App

Keep track of your holdings and explore over 40,000 cryptocurrencies

oinCodex Android App
CoinCodex Mobile App
Market Closed

UNCY
Unicycive Therapeutics
$ 3.55
-4.05%   Last 7D
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Updated 2 days ago